[Clinical studies on serum lipids in the patients with tumor of the prostate gland. 2nd. Report. Changes of serum lipids and lipoprotein fractions during the treatment of estramustine phosphate disodium, hexestrol and diethylstilbestrol 4, 4-diphosphoric ester for the patients with prostatic cancer (author's transl)].
D000368:Aged; D004054:Diethylstilbestrol / Q000031:analogs & derivatives* / Q000494:pharmacology; D004961:Estramustine / Q000494:pharmacology*; D006589:Hexestrol / Q000494:pharmacology*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology*; D011470:Prostatic Hyperplasia / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy
D008055:Lipids; D008074:Lipoproteins; D009588:Nitrogen Mustard Compounds; D006589:Hexestrol; D004961:Estramustine; D004054:Diethylstilbestrol; C004955:fosfestrol